| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 08/12/2005 | 17:01 | PR Newswire (US) | ev3 Inc. Announces Expected Closing Date for Acquisition of Public Minority Stake in Micro Therapeutics, Inc. | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 14/11/2005 | 15:11 | PR Newswire (US) | ev3 Inc. and Micro Therapeutics, Inc. Announce Merger Agreement | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 27/10/2005 | 15:01 | PR Newswire (US) | Micro Therapeutics Reports 72% Increase in 2005 Third Quarter Net Sales | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 27/10/2005 | 15:00 | PR Newswire (US) | ev3 Inc. Reports Third Quarter Financial Results | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 21/10/2005 | 16:00 | PR Newswire (US) | ev3 and Micro Therapeutics to Report 2005 Third-Quarter Financial Results and Host Joint Conference Call on October 27, 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/10/2005 | 16:30 | PR Newswire (US) | ev3 Inc. Proposes to Acquire Public Minority Stake in Micro Therapeutics, Inc. | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/10/2005 | 15:30 | PR Newswire (US) | Micro Therapeutics, Inc. Announces Receipt of Exchange Offer Proposal From ev3 Inc. | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 05/10/2005 | 20:04 | PR Newswire (US) | Micro Therapeutics, Inc. Reports Sales Results for Third Quarter 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 02/08/2005 | 23:51 | PR Newswire (US) | Micro Therapeutics Reports 44% Increase in Net Sales for 2005 Second Quarter; Company Raises Sales Guidance for 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 02/08/2005 | 23:48 | PR Newswire (US) | ev3 Inc. Reports Second Quarter Financial Results | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 27/07/2005 | 22:27 | PR Newswire (US) | ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 22/07/2005 | 00:27 | PR Newswire (US) | ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 22/07/2005 | 00:08 | PR Newswire (US) | Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 07/07/2005 | 00:30 | PR Newswire (US) | Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 28/04/2005 | 23:14 | PR Newswire (US) | Micro Therapeutics Reports 50% Net Sales Increase for 2005 First Quarter | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 25/04/2005 | 19:28 | PR Newswire (US) | Micro Therapeutics to Report First Quarter Financial Results and Host Conference Call on April 28, 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 21/03/2005 | 22:57 | PR Newswire (US) | ev3 Announces Enrollment Has Begun for SpideRX(TM) Embolic Protection Device in Second Phase of Carotid Clinical Trial | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/02/2005 | 21:23 | PR Newswire (US) | Micro Therapeutics Reports Record Revenue in 2004 Fourth Quarter and Full Year Financial Results | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/02/2005 | 13:45 | PR Newswire (US) | Reminder - Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 08/02/2005 | 00:40 | PR Newswire (US) | Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 01/02/2005 | 13:00 | PR Newswire (US) | Micro Therapeutics Receives $3.7 Million Payment | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 29/12/2004 | 18:13 | PR Newswire (US) | Micro Therapeutics Consolidates Manufacturing Capabilities | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 06/12/2004 | 21:04 | PR Newswire (US) | ev3 Receives Investigational Device Exemption for Use of SpideRX(TM) Embolic Protection Device in Clinical Trial | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/11/2004 | 15:00 | PR Newswire (US) | ev3 International Files Lawsuit Against Distributors in Hong Kong and Phoenix | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 04/11/2004 | 13:00 | PR Newswire (US) | Micro Therapeutics Reports 2004 Third Quarter Financial Results | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 01/11/2004 | 21:24 | PR Newswire (US) | Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 21/10/2004 | 17:47 | PR Newswire (US) | FDA Grants Marketing Clearance to ev3 for Protege(R) GPS(TM) Long Stents | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 21/09/2004 | 15:01 | PR Newswire (US) | ev3(TM) Receives 510(k) Marketing Clearance for X-SIZER(R) Thrombectomy Catheter System for Dialysis Graft Use | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 26/08/2004 | 18:33 | PR Newswire (US) | ev3 Receives CE Mark Approval for Tapered Stents for Carotid Stenting Procedures | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 18/08/2004 | 19:51 | PR Newswire (US) | Micro Therapeutics Completes Issuance of Common Stock for Exchangeable Notes | NASDAQ:MTIX | Micro Therapeutics (MM) |